Entera Health, Inc. Announces Presentations at Digestive Disease Week 2014

Three upcoming presentations will be hosted by Entera Health at Digestive Disease Week DDW® 2014 in Chicago, IL, Saturday, May 3 – Tuesday, May 6.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Entera Health

Cary, NC (PRWEB) April 29, 2014

Entera Health Inc. is pleased to announce three important presentations taking place during DDW next week.

Food and Nutrition: An Endangered and Integral Part of Gastroenterology, Neurology, Allergy and Immunology, Endocrinology, ID, etc.

Presented by Bruce Burnett, PhD, Senior Director of Compliance, Regulatory, and Medical Affairs at DDW® 2014 Rome Foundation Advisory Council Meeting on Saturday, May 3rd, 2014

Serum-derived bovine immunoglobulin/ protein isolate binds and neutralizes Clostridium difficile toxins A and B.Henderson, A.L., Horgan, A., Detzel, C.J, Maas, K.J., Weaver, E.M.

DDW® 2014 Poster ID: Sa1759 - Saturday, May 3rd, 2014 (12-2pm)

Serum-derived Bovine Immunoglobulin/ Protein Isolate Attenuated DSS-induced Colitis in a Defined Floral Model

Maas, K., Wymore Brand, M., Henderson, A., Detzel, C., Horgan, A., Darling, R., Hostetter, J., Phillips, G., Jergens, A., Wannemuehler, M.J., Darling, R., Weaver, E.M.

DDW® 2014 Poster ID: Mo1708 - Monday, May 5th, 2014 (12-2pm)

About The Rome Foundation
The Rome Foundation is an independent not for profit 501(c)(3) organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of functional gastrointestinal disorders (FGIDs). Its mission is to improve the lives of people with functional GI disorders. Visit them at http://www.romecriteria.org/.

About EnteraGam™
EnteraGam™ (serum-derived bovine immunoglobulin/protein isolate, SBI) is a new prescription medical food product to help people manage ongoing problems with chronic loose and frequent stools (diarrhea). EnteraGam™ is required to be used under physician supervision as part of ongoing medical care for a specific condition or disease. EnteraGam™ is indicated for the clinical dietary management of enteropathy in patients who, because of therapeutic or chronic medical needs, have limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients. Visit our product website at http://enteragam.com/.

About Entera Health, Inc.
Entera Health, Inc. is focused on improving worldwide health through the development of clinically safe biotherapeutics to address unmet needs. Our passion is to help people thrive through healthier living. Our motivation for conducting basic research, clinical studies, and appropriately educating patients and healthcare providers is driven to meet this goal. Visit us at http://www.enterahealth.com/.


Contact